Clinical application value of postoperative ctDNA detection in minimal residual disease monitoring of lung cancer based on liquid biopsy technology.
APA
Yuan R, He H, Wu M (2026). Clinical application value of postoperative ctDNA detection in minimal residual disease monitoring of lung cancer based on liquid biopsy technology.. Current problems in surgery, 76, 101976. https://doi.org/10.1016/j.cpsurg.2025.101976
MLA
Yuan R, et al.. "Clinical application value of postoperative ctDNA detection in minimal residual disease monitoring of lung cancer based on liquid biopsy technology.." Current problems in surgery, vol. 76, 2026, pp. 101976.
PMID
41796517
같은 제1저자의 인용 많은 논문 (5)
- Oncolytic Vaccinia Virus-HSP70-shRNA Amplifies Viral Replication, ROS/Autophagy, and Immunity to Fight Colorectal Cancer.
- A rationally designed bispecific antibody targeting GPC3 and PD-L1 induces tumor-directed immune activation and cytotoxicity.
- Deceptive initial presentation of systemic DLBCL with CNS progression following Oligometabolic PET/CT: case report.
- Clinico-genomic characterization of RAS-mutant acute myeloid leukemia.
- Deconjugating taurocholic acid with Bifidobacterium to mitigate obesity-driven cancer progression by restoring CD8 T-cell infiltration.